OWC Pharmaceutical Research Corp. (OWCP) Financial Statements (2024 and earlier)

Company Profile

Business Address 2 BEN GURION ST.
RAMAT GAN, 5257334
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,8402,8003,4644,2194,649692
Cash and cash equivalents1,8402,8003,4644,2194,649692
Prepaid expense      12
Other current assets40954526092 
Total current assets:2,2492,8543,5164,2794,741703
Noncurrent Assets
Operating lease, right-of-use asset5360
Property, plant and equipment333537333333
Total noncurrent assets:869537333333
TOTAL ASSETS:2,3352,9493,5534,3124,774736
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1041639823112871
Accounts payable1041639823112871
Deferred revenue 100100
Debt2626    
Estimated litigation liability   1515  
Other liabilities2862202407015164
Deferred revenue and credits100
Other undisclosed current liabilities   8585100 
Total current liabilities:516509438401379234
Noncurrent Liabilities
Long-term debt and lease obligation:2734    
Operating lease, liability2734
Other undisclosed noncurrent liabilities1,2079,70810,3296,3666,045 
Total noncurrent liabilities:1,2349,74210,3296,3666,045 
Other undisclosed liabilities    0  
Total liabilities:1,75010,25110,7676,7686,424234
Temporary equity, carrying amount3,6282,9402,2261,336533 
Equity
Equity, attributable to parent, including:(3,043)(10,242)(9,440)(3,791)(2,183)502
Common stock422111
Common stock, share subscribed but unissued, subscriptions receivable(239)(239)(239)(239)(239)(239)
Additional paid in capital19,62519,35318,13717,74617,52816,514
Accumulated other comprehensive income (loss)143233
Accumulated deficit(22,384)(29,276)(27,222)(21,144)(19,282)(15,494)
Other undisclosed equity, attributable to parent(50)(86)(121)(157)(194)(284)
Other undisclosed equity    (0)  
Total equity:(3,043)(10,242)(9,440)(3,791)(2,183)502
TOTAL LIABILITIES AND EQUITY:2,3352,9493,5534,3124,774736

Income Statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues 100(100)   
Other operating income      
Gross profit: 100    
Operating expenses715(783)(1,682)(669)(968)(977)
Other undisclosed operating loss   (100)   
Operating income (loss):715(683)(1,782)(669)(968)(977)
Nonoperating income (expense)8,422217(2,562)3222,242 
Income (loss) from continuing operations:9,137(466)(4,344)(347)1,274(977)
Income (loss) before gain (loss) on sale of properties:9,137(466)(4,344)(347)1,274(977)
Net income (loss):9,137(466)(4,344)(347)1,274(977)
Other undisclosed net loss attributable to parent(1,430)(534)(736)(644)(4,484)(1)
Net income (loss) attributable to parent:7,707(1,000)(5,080)(991)(3,210)(977)
Preferred stock dividends and other adjustments(813)(1,054)(998)(871)(578) 
Other undisclosed net income (loss) available to common stockholders, basic (3)(1)(13,255)3,7257,576 
Net income (loss) available to common stockholders, diluted:6,891(2,055)(19,332)1,8623,788(977)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income (loss):9,137(466)(4,344)(347)1,274(977)
Other comprehensive income (loss)   29923,210(3)
Other undisclosed comprehensive income (loss)(16,841)1,46514,557   
Comprehensive income (loss), net of tax, attributable to parent:(7,704)99910,2156454,484(980)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: